×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

CureVac's Covid-19 vaccine triggers immune response in Phase I trial

The biotech firm is using the so-called messenger RNA (mRNA) approach, the same as Moderna as well as BioNTech
Last Updated : 02 November 2020, 12:49 IST

Follow Us :

Comments
ADVERTISEMENT
Published 02 November 2020, 12:49 IST

Follow us on :

Follow Us